The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis: Review

British Journal of Haematology

Volumn 150, Issue 1, 2010, Pages 3-8

  Andrès, Emmanuel ^a   Maloisel, Frédéric ^b   Zimmer, Jacques ^c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Clinique Sainte Anne   (France)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Agranulocytosis; Cytokine; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Haematopoietic growth factors; Neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; RATIOGRASTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

AGRANULOCYTOSIS; AMBULATORY CARE; DRUG EFFICACY; DRUG INDUCED AGRANULOCYTOSIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; GRANULOCYTE TRANSFUSION; HUMAN; MORBIDITY; MORTALITY; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT DURATION;

AGED; AGRANULOCYTOSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; PROGNOSIS;

EID: 77953518258     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08104.x     Document Type: Review

References (22)

1. Andersohn, F., Konzen, C. Garbe, E. (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Annals of Internal Medicine, 146, 657 665.
2. Andrès, E. Maloisel, F. (2008) Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Current Opinion in Hematology, 15, 15 21.
3. Andrès, E., Maloisel, F., Kurtz, J.E., Vinzio, S., Sibilia, J., Schlienger, J.L. Dufour, P. (2000) Les facteurs de croissance hématopoïétique ont-ils une place dans le traitement des agranulocytoses médicamenteuses? Revue de Médecine Interne, 21, 580 585.
4. Andrès, E., Kurtz, J.E., Perrin, A.E., Dufour, P., Schlienger, J.L. Maloisel, F. (2001) Haematopoietic growth factor in antithyroid-drug- induced agranulocytosis. Quarterly Journal of Medicine, 94, 423 428.
5. Andrès, E., Maloisel, F., Kurtz, J.E., Kaltenbach, G., Alt, M., Weber, J.C., Sibilia, J., Schlienger, J.L., Blicklé, J.F., Brogard, J.M. Dufour, P. (2002a) Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. European Journal of Internal Medicine, 13, 324 328.
6. Andrès, E., Kurtz, J.E. Maloisel, F. (2002b) Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. Clinical and Laboratory Haematology, 24, 99 106.
7. Andrès, E., Kurtz, J.E., Martin-Hunyadi, C., Kaltenbach, G., Alt, M., Weber, J.C., Sibilia, J., Schlienger, J.L., Dufour, P. Maloisel, F. (2002c) Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. American Journal of Medicine, 112, 460 464.
8. Andrès, E., Noel, E. Maloisel, F. (2004) Long-term outcome of patients treated with hematopoietic growth factors for idiosyncratic drug-induced agranulocytosis. American Journal of Medicine, 116, 354.
9. Beauchesne, M.F. Shalansky, S.J. (1999) Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors. Pharmacotherapy, 19, 299 305.
10. Carey, P.J. (2003) Drug-induced myelosuppression: diagnosis and management. Drug Safety, 26, 691 706.
11. Fukata, S., Kuma, K. Sugawara, M. (1999) Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid, 9, 29 31.
12. Hamerschlak, N., Maluf, E., Biasi Calvalcanti, A., Junior, A.A., Eluf-Neto, J., Passeto Falcao, R., Heidemarie Lorand-Metze, I.G., Goldenberg, D., Leite Santana, C., Werneck Rodrigues, D., Da Motta Passos, L.N., De Miranda Coelho, E.O., Tostes Pintao, M.C., Moraes de Souza, H., Rafael Borbolla, J. Pasquini, R. (2008) Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study: a multicenter study. European Journal of Clinical Pharmacology, 64, 921 929.
13. Hughes, W.T., Armstrong, D., Bodey, G.P., Bow, E.J., Brown, A.E., Calandra, T., Feld, R., Pizzo, P.A., Rolston, K.V., Shenep, J.L. Young, L.S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Disease, 34, 730 751.
14. Ibáñez, L., Vidal, X., Ballarín, E. Laporte, J.R. (2005) Population-based drug-induced agranulocytosis. Archives of Internal Medicine, 165, 869 874.
15. Ibáñez, L., Sabaté, M., Ballarín, E., Puig, R., Vidal, X., Laporte, J.R the Agranulocytosis and Aplastic Anaemia Study Group of Barcelona 2008) Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis. Pharmacoepidemiol Drug Safety, 17, 224 228.
16. Juliá, A., Olona, M., Bueno, J., Revilla, E., Rosselló, J., Petit, J., Morey, M., Flores, A., Font, L. Maciá, J. (1991) Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. British Journal of Haematology, 79, 366 371.
17. Maloisel, F., Andrès, E., Kaltenbach, G., Noel, E. Koumarianou, A. (2003) Prognostic factors of hematologic recovery in nonchemotherapy drug-induced agranulocytosis. Haematologica, 88, 470 471.
18. Márquez, J.A., Pardo, C., Amutio, E., Cortés, C., Piñán, M.A. Alvarez, C. (1998) Drug-induced agranulocytosis: clinical study of 19 cases. Sangre (Barcelona), 43, 436 438.
19. Paitel, J.F., Stockemer, V., Dorvaux, V., Witz, F., Guerci, A. Lederlin, P. (1995) Agranulocytoses aiguës médicamenteuses. Etude clinique à propos de 30 patients et évolution des étiologies sur 2 décennies. Revue de Médecine Interne, 16, 495 499.
20. Patton, W.N. Duffull, S.B. (1994) Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance. Drug Safety, 11, 445 462.
21. Sprikkelman, A., de Wolf, J.T. Vellenga, E. (1994) The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia, 8, 2031 2036.
22. Vial, T., Gallant, C., Choqu-Kastylevsky, G. Descotes, J. (1999) Treatment of drug-induced agranulocytosis with haematopoietic growth factors: a review of the clinical experience. BioDrugs, 11, 185 200.